StatisticaMedica Leadership

Under Gloria’s leadership and strategic direction, StatisticaMedica continues to grow its Biostatistics and Consulting Services, with expertise in advanced statistical methods and study design. Gloria provides expert-level input and advice to sponsors on study design and regulatory requirements, including attendance at notified regulatory body meetings (FDA and EMA) in a Senior Biostatistician advisory role. As Director of Biostatistics, Gloria contributes at a senior level to various aspects of biostatistical design and analysis, overseeing the statistical validity of trial data and quality processes for deliverables. She provides strategic direction for company operations, including development of resource capacity and capabilities. Furthermore, Gloria provides strategic direction for innovative statistical methods for complex study design and novel therapeutic and diagnostic areas of analysis, e.g., use of simulation for in silico trials. Gloria is a Scientific Advisor to the EU IMI initiative and is a member of several Data Monitoring and Safety Committees for innovative drugs (e.g., for rare paediatric diseases) in the EU and US.